Regulation of research subjects mesenchymal stem cell functions by an autocrine loop [PMID: 20964598] Laboratory literature summary: Regulation of research subjects mesenchymal stem cell functions by an autocrine loop involving NAD+ release and P2Y11-mediated signaling
The entire vial was used within 8 weeks, well within the stability window
However, the choice of medication must be tailored to your medical condition and your bodys response to treatment, which is why they should always be used under a doctors supervision
While some studies have shown potential benefits positively affecting certain brain functions, much of the evidence comes from small studies or animal studies
The starting dose for severe deficiency is typically 1500mcg (the full dose of the 1ml vial) given daily or on alternate days for 1 to 2 weeks, or until haematological remission is achieved
In summary, I believe that BPC-157 may have utility for soft tissue injuries, perhaps more so for those whom other interventions did not help